ReviewFrontiers in immunology2022

Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions.

Peng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.